Oncolytics Biotech
ONCY
$1.19
Share price
0.85%
Change (1 day)
-30.41%
Change (1 year)
Categories
Operating Margin for Oncolytics Biotech (ONCY)
Operating Margin as of May 2024 (TTM): -1,631.66%
According to Oncolytics Biotech 's latest financial reports and stock price the company's current Operating Margin is -1,631.66%. At the end of 2005 the company had an Operating Margin of -1,631.66%.
Operating Margin history for Oncolytics Biotech from 2001 to 2007
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2005 | -1,631.66% | -11.87% |
| 2004 | -1,851.52% | -31.84% |
| 2003 | -2,716.36% | -15.96% |
| 2002 | -3,232.38% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | 24.66% | -101.51% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | -101.18% | 🇺🇸 USA |
 Mirati Therapeutics MRTX | -5,953.35% | 264.86% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | -161.15% | -90.12% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -20.53% | -98.74% | 🇮🇱 Israel |
 AVEO Oncology
AVEO | -30.78% | -98.11% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.